1-18 of 18
Authors: Adam Cohen
Journal Article
BIOM-12. ALLIANCE A071401: GENOMICALLY GUIDED PHASE II TRIAL OF ABEMACICLIB IN PATIENTS WITH GRADE 2/3 MENINGIOMAS HARBORING SOMATIC NF2 OR CDK PATHWAY ALTERATIONS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii21, https://doi.org/10.1093/neuonc/noae165.0085
Published: 11 November 2024
Journal Article
LTBK-09. RESULTS OF BMX-HGG STUDY: A MULTI-INSTITUTIONAL, RANDOMIZED PHASE 2 CLINICAL TRIAL OF CONCURRENT CHEMORADIATION WITH OR WITHOUT BMX-001 IN PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v311, https://doi.org/10.1093/neuonc/noad179.1203
Published: 17 November 2023
Journal Article
CTNI-73. ALLIANCE A071601: PHASE II TRIAL OF BRAF/MEK INHIBITION IN NEWLY DIAGNOSED PAPILLARY CRANIOPHARYNGIOMAS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v94, https://doi.org/10.1093/neuonc/noad179.0355
Published: 10 November 2023
Journal Article
INNV-33. FUNCTIONAL EX VIVO TESTING PROSPECTIVELY IDENTIFIES NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS SENSITIVE TO TEMOZOLOMIDE TREATMENT IRRESPECTIVE OF MGMT METHYLATION STATUS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii148–vii149, https://doi.org/10.1093/neuonc/noac209.573
Published: 14 November 2022
Journal Article
CTNI-05. MOLECULAR ANALYSIS OF THE PHASE I D-TERMINED TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE WITH MINOCYCLINE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii70–vii71, https://doi.org/10.1093/neuonc/noac209.272
Published: 14 November 2022
Journal Article
CTIM-05. A PHASE 1/2 STUDY OF THE COMBINATION OF INDOXIMOD AND TEMOZOLOMIDE FOR ADULT PATIENTS WITH TEMOZOLOMIDE-REFRACTORY PRIMARY HIGH-GRADE GLIOMAS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi50, https://doi.org/10.1093/neuonc/noab196.197
Published: 12 November 2021
Journal Article
CTNI-53. RADIATION TREATMENT VOLUMES BEFORE AND AFTER BRAF/MEK THERAPY IN NEWLY DIAGNOSED PAPILLARY CRANIOPHARYNGIOMAS: A CORRELATIVE ANALYSIS OF THE ALLIANCE A071601 PHASE II TRIAL
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi72, https://doi.org/10.1093/neuonc/noab196.278
Published: 12 November 2021
Journal Article
HOUT-16. A RETROSPECTIVE ANALYSIS OF SURVIVAL OUTCOMES BASED ON CONSOLIDATION REGIMENS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi115, https://doi.org/10.1093/neuonc/noz175.481
Published: 11 November 2019
Journal Article
QOLP-09. IMPACT OF GLIOBLASTOMA (GBM) PATIENTS’ CLINICAL AND TREATMENT CHARACTERISTICS ON CAREGIVER BURDEN AND QUALITY OF LIFE (QOL)
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi199, https://doi.org/10.1093/neuonc/noz175.829
Published: 11 November 2019
Journal Article
PATH-54. UTILITY OF NEXT GENERATION SEQUENCING IN ADULT PRIMARY BRAIN TUMORS: IMPACT ON DIAGNOSIS AND PERSONALIZED THERAPY
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi170, https://doi.org/10.1093/neuonc/noy148.708
Published: 05 November 2018
Journal Article
ACTR-19. A MULTICENTER PILOT PHASE II STUDY OF CONTINUING TMZ WITH THE ADDITION OF DISULFIRAM AND COPPER FOR REFRACTORY GLIOBLASTOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi15, https://doi.org/10.1093/neuonc/noy148.053
Published: 05 November 2018
Journal Article
HOUT-01. A RETROSPECTIVE ANALYSIS OF OUTCOMES WITH TEMOZOLOMIDE AS INITIAL TREATMENT OF GRADE 2 OLIGODENDROGLIOMA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi113, https://doi.org/10.1093/neuonc/noy148.469
Published: 05 November 2018
Journal Article
HOUT-19. DEVELOPMENT OF A NOVEL BURDEN SURVEY FOR CAREGIVERS OF GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi110, https://doi.org/10.1093/neuonc/nox168.450
Published: 06 November 2017
Journal Article
ACTR-84. D-TERMINED: A PHASE 1 TRIAL IN NEWLY DIAGNOSED HIGH GRADE GLIOMA WITH TEMOZOLOMIDE, RADIATION, AND MINOCYCLINE FOLLOWED BY ADJUVANT MINOCYCLINE/TEMOZOLOMIDE
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi19, https://doi.org/10.1093/neuonc/nox168.070
Published: 06 November 2017
Journal Article
EPID-11. THE CONTRIBUTION OF THE rs55705857 G ALLELE TO FAMILIAL CANCER RISK USING THE UTAH POPULATION DATABASE
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi57, https://doi.org/10.1093/neuonc/now212.237
Published: 07 November 2016
Journal Article
NIMG-08EVALUATION OF 2HG MR SPECTROSCOPY IN RELATION TO DISEASE ACTIVITY IN GLIOMAS
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v154, https://doi.org/10.1093/neuonc/nov225.08
Published: 09 November 2015
Journal Article
MPTH-05NEXT GENERATION SEQUENCING OF GLIOMAS REFINES DIAGNOSIS AND IDENTIFIES TARGETABLE ALTERATIONS IN CLINICAL PRACTICE, BUT RESULTS DEPEND ON THE ASSAY
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v138–v139, https://doi.org/10.1093/neuonc/nov222.05
Published: 09 November 2015
Journal Article
DISTINCT COPY NUMBER ALTERATIONS AND INCIDENCE OF CHROMOTHRIPSIS ASSOCIATED WITH GRADE AND PROGNOSIS IN IDH MUTANT AND WILD-TYPE GLIOMAS Get access
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii6, https://doi.org/10.1093/neuonc/nou206.20
Published: 01 July 2014
